Training Academy
Careers
We place high value on performance excellence, safe working conditions, and to provide opportunities for our employees to optimise their professional growth.
Knowledge Hub
Services
Frequently asked questions: SARS-CoV-2 B.1.1.529/Omicron variant
On 26 November 2021 the WHO designated the new SARS-CoV-2 lineage B.1.1.529, now named Omicron, a variant of concern.
Much is still unknown about Omicron and it is expected that the variant’s real world impact will become clearer over the next weeks.
Covid-19 associated pulmonary aspergillosis (CAPA)
In individuals with co-morbidities, defective immune responses to SARS-CoV-2 may allow unrestricted viral replication which elicits hyperinflammation and severe complications such as acute respiratory distress syndrome (ARDS).
COVID-19 resulting in ARDS has recently emerged as an important disease that predisposes patients to secondary pulmonary aspergillosis.
Advances in molecular oncology: Liquid biopsy for non-small cell lung cancer
In recent years, liquid biopsies have emerged as a promising tool in the fields of molecular oncology and precision medicine. Liquid biopsy methodology typically analyses genomic DNA isolated from circulating tumour cells (CTCs) or circulating cell-free tumour DNA (cfDNA/ctDNA) in a peripheral blood sample, to gain insight into the genomic profile of the patients’ tumour.